Introduction: Yangzhou Nori Pharmaceutical Co., Ltd. (formerly known as: Yangzhou Kelimeng Health Pharmaceutical Factory) was founded in August 1996. It is a company integrating research and development, production and sales and has self-operated exports. A modern enterprise specializing in the production of pharmaceuticals. The company is located in the eastern suburbs of Yangzhou, a city that won the "United Nations Human Settlements Award": No. 99 Zhenxing Road, Xiaoji Town, Jiangdu City. The transportation is very convenient. The Beijing-Shanghai Expressway and Ningtong Expressway intersect here; the Yangtze River, the Beijing-Hangzhou Canal and the Huaihe River It is gathered here; it is 180km away from Nanjing Lukou Airport, and the upcoming Suzhong Airport will be located here. The company covers an area of ??18,000 square meters, including a building area of ??5,900 square meters, roads and squares of 2,399 square meters, and green coverage accounting for 33% of the total area. The production plant and warehouse are 1,280 square meters, the production workshop is 1,080 square meters, the warehouse is 350 square meters, the office building is 380 square meters, and the quality inspection center is 350 square meters. The production plant and production lines for hard capsules, tablets and granules have passed the national GMP certification. The company's current annual production capacity is 1 billion hard capsules, 300 million tablets and 200 million bags of granules. Our company passed the GMP certification for pharmaceutical manufacturers for the second time on August 19, 2010. The company's registered capital is RMB 30 million. The company currently has 39 employees, including 20 technical personnel of various types, accounting for 51% of the total number of employees (including 2 with senior professional titles and 7 with intermediate professional titles). The management organizations are as follows: Production Department, Quality Assurance Department Department, Engineering Department, Finance Department, Office. The company's existing products: "Whole Turtle Capsule" is a pharmaceutical preparation made from the fresh and whole body of Chinese soft-shell turtle, which has been rested and sterilized using modern high-tech equipment and advanced technology. The company began to develop and produce "Quan Turtle Capsules" health care drugs in 1992 (now applied for a national patent). The products are supplied to domestic and foreign markets. This product especially has a definite therapeutic effect on leukopenia caused by tumor radiotherapy and chemotherapy, and many tumors and hepatitis diseases. Patients' symptoms can be significantly improved soon after taking this product; at the same time, it has a good auxiliary therapeutic effect on patients with liver and kidney yin deficiency caused by illness or deficiency. For this reason, we developed it into a new drug: "Quan Turtle Capsule", a national new drug, and obtained the new drug certificate on April 22, 2005 (approval number: National Drug Approval No. B20050028), enjoying the exclusive national production rights. This variety is now available The national bureau is changing its name to "Bilikan" capsules. Since its establishment, Nori Pharmaceuticals has aimed to become bigger and stronger and become an international enterprise. It has continuously accelerated the pace of scientific and technological innovation and independent brand building to build the company's core competitiveness, and the company's comprehensive economic strength has been rapidly improved. In the development of the enterprise, we adhere to the development path of "revitalizing the enterprise through science and technology" and "strengthening the enterprise through science and technology". Most of the profits earned by enterprises every year are used for technological innovation and development expenditures. In addition to independent research and development, we also cooperate with well-known domestic experts and major university research institutions through industry-university-research cooperation to jointly develop and imitate new generation products. Nori Pharmaceuticals focuses on creating a people-oriented corporate culture and strives to build a harmonious enterprise. While vigorously developing the economy, Nori has always regarded ideological and political work as the "lifeline" of the company's economic work, and the party, government and working groups have jointly taken charge of it. Educate employees on patriotism, collectivism, socialism and the spirit of hard work and entrepreneurship, and strive to cultivate employees into new socialist people with ideals, ethics, culture and discipline. Influenced by the spirit of Nori Pharmaceuticals, everyone consciously works hard, strives for self-improvement, unites and cooperates, loves the factory as much as home, is honest and self-disciplined, and works selflessly. This has supported Nori's yesterday and today, and will also support Nori's greater glory. tomorrow, a better future! Better serve human health. In order to actively explore domestic and foreign markets, the company is using various marketing methods such as franchise franchises and provincial agents to establish sales networks at home and abroad. At the same time, we hope to win the favor of people of insight, provide more support and cooperation, develop more high, new and advanced new drug varieties, and make the company stronger and bigger as soon as possible. Make greater contributions to human health!
Legal representative: Xie Shixiang
Establishment date: 1993-03-04
Registered capital: RMB 75.8799 million
Industrial and commercial registration No.: 321088000011191
Enterprise type: Limited liability company
Company address: No. 99, Fumin Zhenxing Road, Xiaoji Town, Jiangdu District, Yangzhou City